Fulton Bank’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$336K Buy
870
+10
+1% +$3.71K 0.01% 573
2026
Q1
$252K Buy
860
+5
+0.6% +$1.64K 0.01% 595
2025
Q4
$300K Buy
855
+48
+6% +$16.2K 0.01% 554
2025
Q3
$261K Sell
807
-909
-53% -$283K 0.01% 582
2025
Q2
$667K Buy
1,716
+176
+11% +$70.8K 0.02% 363
2025
Q1
$670K Buy
1,540
+460
+43% +$185K 0.03% 350
2024
Q4
$398K Sell
1,080
-49
-4% -$20.5K 0.02% 476
2024
Q3
$587K Sell
1,129
-1
-0.1% -$534 0.02% 373
2024
Q2
$612K Buy
1,130
+31
+3% +$16.4K 0.02% 345
2024
Q1
$570K Sell
1,099
-50
-4% -$24.9K 0.02% 366
2023
Q4
$542K Sell
1,149
-119
-9% -$55K 0.02% 360
2023
Q3
$552K Buy
1,268
+19
+2% +$8.62K 0.03% 336
2023
Q2
$555K Sell
1,249
-113
-8% -$52.1K 0.03% 326
2023
Q1
$626K Buy
1,362
+179
+15% +$85.2K 0.03% 298
2022
Q4
$607K Buy
1,183
+59
+5% +$30K 0.03% 288
2022
Q3
$510K Buy
1,124
+109
+11% +$52.2K 0.03% 294
2022
Q2
$490K Buy
1,015
+14
+1% +$6.93K 0.03% 305
2022
Q1
$491K Sell
1,001
-42
-4% -$19.2K 0.02% 324
2021
Q4
$484K Hold
1,043
0.02% 339
2021
Q3
$389K Sell
1,043
-1,685
-62% -$640K 0.02% 366
2021
Q2
$1.04M Sell
2,728
-133
-5% -$50.8K 0.05% 224
2021
Q1
$1.03M Sell
2,861
-204
-7% -$65.6K 0.05% 216
2020
Q4
$984K Sell
3,065
-107
-3% -$32.8K 0.05% 212
2020
Q3
$852K Sell
3,172
-339
-10% -$91.2K 0.05% 207
2020
Q2
$923K Sell
3,511
-4,996
-59% -$1.33M 0.06% 203
2020
Q1
$1.93M Buy
8,507
+256
+3% +$69.8K 0.15% 119
2019
Q4
$2.49M Sell
8,251
-268
-3% -$73.8K 0.15% 123
2019
Q3
$2.05M Buy
8,519
+182
+2% +$49.9K 0.14% 128
2019
Q2
$2.35M Buy
8,337
+710
+9% +$194K 0.16% 116
2019
Q1
$2.19M Sell
7,627
-599
-7% -$173K 0.15% 119
2018
Q4
$2.16M Buy
8,226
+317
+4% +$87.2K 0.17% 112
2018
Q3
$2.17M Buy
7,909
+2,131
+37% +$553K 0.14% 129
2018
Q2
$1.38M Sell
5,778
-169
-3% -$39.1K 0.1% 162
2018
Q1
$1.31M Sell
5,947
-372
-6% -$87.4K 0.09% 160
2017
Q4
$1.42M Buy
6,319
+280
+5% +$59.6K 0.1% 151
2017
Q3
$1.15M Buy
6,039
+2,991
+98% +$569K 0.09% 164
2017
Q2
$574K Buy
3,048
+511
+20% +$91.8K 0.04% 217
2017
Q1
$420K Buy
2,537
+776
+44% +$123K 0.03% 274
2016
Q4
$253K Buy
+1,761
New +$236K 0.02% 356

Other funds holding ELV

Fulton Bank's ELV Position: Q2 2026 in Review

Fulton Bank increased its Elevance Health (ELV) stake by 1.2% in Q2 2026, buying an estimated $3.71K and bringing the position to 870 shares worth $336K. The position accounts for 0.01% of the portfolio, ranked #573.

Fulton Bank first reported a position in ELV in Q4 2016 and has held it in 39 quarters since. The position peaked at $2.49M in Q4 2019. 291 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Fulton Bank held 870 shares of Elevance Health worth $336K as of Q2 2026.
  • Fulton Bank bought 10 Elevance Health shares in Q2 2026, an estimated $3.71K.
  • Elevance Health made up 0.01% of Fulton Bank's portfolio in Q2 2026, its #573 holding.
  • Fulton Bank first reported a position in Elevance Health in Q4 2016 and has held it in 39 quarters since.
  • Fulton Bank's Elevance Health position peaked at $2.49M in Q4 2019.
  • 291 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Fulton Bank's 13F filing for Q2 2026, filed 9 Jul 2026.